Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care
- PMID: 26389529
- PMCID: PMC4835263
- DOI: 10.1111/bju.13329
Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care
Abstract
Objectives: To determine the relationship between long-term prostate cancer survivors' symptom burden and information needs.
Patients and methods: We used population-based data from the Michigan Prostate Cancer Survivor Study (2499 men). We examined unadjusted differences in long-term information needs according to symptom burden and performed multivariable logistic regression to examine symptom burden and information needs adjusting for patient characteristics.
Results: High symptom burden was reported across all domains (sexual 44.4%, urinary 14.4%, vitality 12.7%, bowel 8.4%, emotional 7.6%) with over half of respondents (56%) reporting they needed more information. Top information needs involved recurrence, relationships, and long-term effects. Prostate cancer survivors with high symptom burden more often searched for information regardless of domain (P < 0.05). High sexual burden was associated with greater need for information about relationships [odds ratio (OR) 2.05, 95% confidence interval (CI) 1.54-2.72] and long-term effects (OR 1.60, 95% CI 1.23-2.07). High bowel burden was associated with greater information need for long-term effects (OR 2.28, 95% CI 1.43-3.63).
Conclusions: Long-term prostate cancer survivors with high symptom burden need more supportive information. Tailoring information to these needs may be an efficient approach to support the growing population of long-term prostate cancer survivors.
Keywords: information needs; quality; self-management; survivorship; tailoring.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.
Figures
Comment in
-
Tailored prostate cancer survivorship: one size does not fit all.BJU Int. 2016 Sep;118(3):343-4. doi: 10.1111/bju.13363. BJU Int. 2016. PMID: 27524717 No abstract available.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2010 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013. [cited 2015 Jun 5]. Available from: Available from: http://globocan.iarc.fr.
-
- Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45. - PubMed
-
- Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors. New England Journal of Medicine. 2008;358(12):1250–61. - PubMed
-
- Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Journal of the National Cancer Institute. 2009;101(12):888–92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
